ARCHIVES

WHI community Prevention Study Concept Approved

This article is from The Cancer Letter archive.

Vol. 19 No. 45 | November 19, 1993

Download PDF Visit The Full Archive

Related Articles

FDA News: FDA Lifts Clinical Hold On CTI’s Tosedostat

January 31, 2014

Broder; Cancer Act’s Special Authorities Don’t Give Director Immunity For NIH, HHS

September 27, 1991

Funding opportunities listed.

October 17, 2003

Broder Appointment Official; Will Keep Retroviral Laboratory, Will Not Serve as NCI Clinical Director

January 6, 1989

Cooperative Groups Other Investigators To Get Interferon When Available; DCT Recompetitions Okayed

April 4, 1980

FDA Adopts Final Diagnostics X-Ray Rule Amendment

September 9, 1977